• DFCP1, ATGL, and the Limits of Lipolysis Evidence

  2026-10-11

  A source-grounded overview of reported evidence that DFCP1 regulates starvation-associated ATGL activity on lipid droplets, with attention to mechanistic interpretation, study provenance, and the limited applicability of protease-inhibitor product claims to this research context.

• Protease Inhibitor Cocktail K1008 Overview

  2026-10-10

  APExBIO’s K1008 is an EDTA-free, 200X protease inhibitor formulation in DMSO. The supplier describes its intended conceptual scope as limiting protein degradation during extraction and related protease-sensitive workflows, but no matched research paper was provided to independently assess performance, compatibility, or outcomes.

• BMPSB4 Activates Autophagy in Corticotroph PitNETs

  2026-10-09

  A 2024 ACS Pharmacology & Translational Science study identifies BMPSB4 as a small-molecule agonist of BMP4-associated signaling that suppresses corticotroph pituitary neuroendocrine tumor models through SMAD-dependent autophagy. The evidence connects reduced BMP4–SMAD1/5/9 activity in Cushing’s disease with tumor inhibition, while remaining preclinical and dependent on cell, tissue, and animal-model findings.

• From Lung-Targeted LNPs to Translational Organoids

  2026-10-09

  Lung-targeted lipid nanoparticles are advancing from empirical discovery toward structure-informed design. This thought-leadership article interprets recent LuT lipid findings, explains what they mean for translational research, and positions the Mouse Lung Organoid Kit as a complementary ex vivo model—not a replacement for animal biodistribution or safety studies.

• AT13387 and the Hsp90–Cell Death Interface

  2026-10-08

  AT13387 is a high-affinity Hsp90 inhibitor for cancer biology research. This article examines how its chaperone-directed pharmacology can be interpreted alongside new evidence that NINJ1 coordinates selective viral protein secretion during programmed cell death.

• Protease Inhibitor Cocktail: Product Overview

  2026-10-08

  APExBIO’s K1008 is an EDTA-free, 200X protease inhibitor cocktail in DMSO, described for conceptual use in limiting protein degradation during protein extraction and related protein-analysis workflows. No matched paper evidence was provided.

• Protease Inhibitor Cocktail in Metabolic Research

  2026-10-07

  A source-grounded overview of how protease inhibition supports protein-focused metabolic research, alongside published findings on puerarin, gut microbiota, adipose thermogenesis, and glucose–lipid metabolism in a type 2 diabetes mouse model.

• Lyotropic Assembly of Coil–Bottlebrush Diblocks

  2026-10-07

  This 2024 Macromolecules study examines how coil–bottlebrush diblock copolymers assemble in a homologous series of alkylimidazolium ionic liquids. Its central finding is that substantially changing ionic-liquid identity produces only weak changes in lyotropic phase behavior, highlighting the importance of polymer architecture and solvent partitioning together rather than solvent chemistry alone.

• Streptavidin–Cy5 in USP42 Breast Cancer Research

  2026-10-06

  The 2025 Scientific Reports study on USP42 presents cell-based, inhibitor-response, and xenograft evidence linking USP42 to reduced JNK/p38 activation and apoptosis in breast cancer models. This overview explains how Streptavidin – Cy5 could fit conceptually within biotin-dependent imaging and flow cytometry research without implying that the reagent was used in that study. It compares the strength of the reported evidence, distinguishes pathway involvement from direct molecular interaction, and outlines limitations affecting clinical translation, assay interpretation, and applicability across breast cancer subtypes.

• Leupeptin Hemisulfate: Evidence and Limits

  2026-10-06

  Leupeptin is a reversible competitive inhibitor of selected serine and cysteine proteases. This overview separates supplier-described applications from evidence in the supplied 2025 TET2 protocol and explains what the available findings can—and cannot—support.

• Exemestane: Mechanism and Research Evidence

  2026-10-05

  Exemestane is a steroidal aromatase inhibitor that suppresses aromatase-mediated estrogen biosynthesis through an enzyme-inactivating mechanism. Its reported biochemical potency is relevant to breast cancer research, but supplier-reported assay values should not be treated as clinical efficacy or as directly comparable across experimental systems.

• Protease Inhibitor Cocktail: Preserving Lysosome Biology

  2026-10-05

  The Protease Inhibitor Cocktail EDTA-Free is examined here as a pre-analytical variable in lysosome research, not merely as a sample-preservation additive. Learn how protease control can strengthen interpretation of protein abundance, complexes, and phosphorylation-related measurements while respecting the limits of the evidence.

• LRPPRC Inhibition and Dasatinib: Dual OXPHOS Blockade

  2026-10-04

  A 2026 study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central contribution is a dual-genome interpretation: LRPPRC inhibition primarily disrupts mitochondrial genome-encoded OXPHOS programs, while dasatinib suppresses nuclear-encoded OXPHOS genes, creating a complementary metabolic blockade.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-10-03

  Saito and colleagues report a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be cryopreserved, differentiated into intestinal epithelial monolayers, and assessed for CYP3A metabolism and P-glycoprotein activity, supporting more human-relevant in vitro pharmacokinetic research.

• AAPH: Designing Better Oxidative Stress Assays

  2026-10-02

  AAPH enables controlled peroxyl-radical generation for reproducible oxidative stress experiments. This guide connects its chemistry to protein-function assays, assay design decisions, and the interpretation of lipid peroxidation readouts.

8562 records 1/571 page Next 12345 下5页 Last page